Catalog Advanced Search

Search by Category
Search by Format
Search by Type
Sort By
Search by Favorites
Search by Category
Search by Format
Search by Type
Search by Speakers
Credits Offered
Search in Packages
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Favorites
Search by Keyword
Sort By
  • Contains 4 Component(s)

    De-Stress Pain Management Case Forum (2024 AC LIVE)

    Learning Objectives:

    • State the role of both prescription and illicit opioids within osteopathic care
    • Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy
    • Analyze case studies to identify opportunities for using Buprenorphine in the treatment of chronic pain or Opioid Use Disorder (OUD)

    Annette T. Carron, DO, MACOI (she/her/hers)

    Director Geriatrics and Palliative Care

    Henry Ford Macomb Hospital

    Past-President ACOI
    Associate Professor, MSU-COM
    Medical Director Heart to Heart Hospice

    Robert Agnello, DO, FACOFP (he/him/his)

    Assistant Professor of Family Medicine

    Campbell University School of Osteopathic Medicine

    Dr. Robert N. Agnello is an assistant professor of family medicine and osteopathic manipulative medicine at Campbell University School of Osteopathic Medicine (CUSOM). He has been adjunct faculty since CUSOM’s inception in 2013, assisting the OMM department. Dr. Agnello is board-certified in family medicine since 2001 and holds a CAQ in pain medicine since 2017. His clinical interests lie in pain management through integrative osteopathic medicine, combining various strategies. His research focuses on complementary care modalities and their impact on pain, including osteopathic manipulation, auricular acupuncture, and functional medicine. Dr. Agnello is actively involved in professional organizations such as the American College of Osteopathic Family Physicians (ACOFP), American Osteopathic Association (AOA), and American Academy of Osteopathy (AAO).

    Dr. Robert N. Agnello, DO, FACOFP has no disclosures.

  • Contains 54 Component(s), Includes Credits

    CME Available: 6.5 AOA Category 1-A credits 6.5 AMA PRA Category 1 Credits™ The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management. Recall the 12 recommendations for clinicians who are prescribing opioids from the CDC Clinical Practice Guidelines for Prescribing Opioids for Pain, 2022. Explain strategies to facilitate safe integration of opioid analgesics into treatment plans with considerations for consistent patient education. Detail strategies to facilitate tapering of opioids following evidence-based practices. Characterize key clinical presentations of patients at risk for opioid disorder or who may be inappropriately using opioids. Review strategies for implementing OMT into treatment regimens.

    The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management.

    • Recall the 12 recommendations for clinicians who are prescribing opioids from the CDC Clinical Practice Guidelines for Prescribing Opioids for Pain, 2022.
    • Explain strategies to facilitate safe integration of opioid analgesics into treatment plans with considerations for consistent patient education.
    • Detail strategies to facilitate tapering of opioids following evidence-based practices.
    • Characterize key clinical presentations of patients at risk for opioid disorder or who may be inappropriately using opioids.
    • Review strategies for implementing OMT into treatment regimens.

    There are 8 courses contained within this series, which will be released on a rolling basis from October 2023 through March 2024. 

    • I. The Etiopathogenesis and Basics of Pain
    • II. Assessment and Measurement of Pain in Patients
    • III. Treatment Planning
    • IV. Non-Pharmacologic Approaches to Pain Management: OMT
    • V. Other Non-Pharmacologic Approaches to Pain Management
    • VI. Pharmacologic Approaches to Pain Management
    • VII. Managing Patients on Opioids
    • VIII. Opioid Use Disorder (OUD)

    Disclosure Statements

    ACOFP and ACOI are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of an ineligible company. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACOFP and ACOI require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). Individuals in a position to control the content may include, but are not limited to, planning committee members, authors, faculty, speakers, reviewers, and activity staff. ACOFP and ACOI review all disclosed relationships to determine which are relevant and then work with the applicable contributors to mitigate the relevant financial relationships. No relevant financial relationships were identified for any individual in control of content for this specific activity series. 

    CME Credit and Designation Statements 

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Osteopathic Family Physicians (ACOFP) and American College of Osteopathic Internists (ACOI). ACOFP is accredited by the ACCME to provide continuing medical education for physicians. ACOFP designates this enduring activity series for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity. ACOFP is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. ACOFP designates this enduring activity series for a maximum of 6.5 AOA Category 1-A credits and will report continuing medical education (CME) credits commensurate with the physician’s participation in this program. 

    Support Acknowledgement 

    The activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. 

    Disclaimer

    ACOFP and ACOI present this information for educational purposes only. The content is provided solely by individuals who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. ACOFP, ACOI, and the supporter assume no liability for the information herein.

    DEA MATE Requirements

    As an accredited organization named in section 1263 of CAA 2023, ACOFP and ACOI have developed this series that may satisfy all or portions of your DEA training requirements.

    Robert Agnello, DO, FACOFP (he/him/his)

    Assistant Professor of Family Medicine

    Campbell University School of Osteopathic Medicine

    Dr. Robert N. Agnello is an assistant professor of family medicine and osteopathic manipulative medicine at Campbell University School of Osteopathic Medicine (CUSOM). He has been adjunct faculty since CUSOM’s inception in 2013, assisting the OMM department. Dr. Agnello is board-certified in family medicine since 2001 and holds a CAQ in pain medicine since 2017. His clinical interests lie in pain management through integrative osteopathic medicine, combining various strategies. His research focuses on complementary care modalities and their impact on pain, including osteopathic manipulation, auricular acupuncture, and functional medicine. Dr. Agnello is actively involved in professional organizations such as the American College of Osteopathic Family Physicians (ACOFP), American Osteopathic Association (AOA), and American Academy of Osteopathy (AAO).

    Dr. Robert N. Agnello, DO, FACOFP has no disclosures.

    Annette T. Carron, DO, MACOI (she/her/hers)

    Director Geriatrics and Palliative Care

    Henry Ford Macomb Hospital

    Past-President ACOI
    Associate Professor, MSU-COM
    Medical Director Heart to Heart Hospice

    Dr. Kathleen M. Farrell, DO

    American College of Osteopathic Family Physicians

    Kathleen M. Farrell, DO, is a graduate of the Arizona College of Osteopathic Medicine. She is certified in family medicine with the American Osteopathic Board of Family Physicians and in addiction medicine with American Osteopathic Academy of Addiction Medicine. Before obtaining her osteopathic medical degree, she earned her bachelor's degree in social welfare at the University of Washington. She is currently working for the VA in the opioid safety clinic in the pain department at American Lakes in Tacoma, Washington.  


    She got her "XF" soon after she got out of residency and when she started a practice with a Valley Family Health Care, a federally qualified health center in New Plymouth, Idaho. While in Idaho, she founded the Idaho Osteopathic Physicians Association and started using buprenorphine to treat her patients on illicit opioidsShe continued this work when she moved to Port Angeles, Washington, to work at the Jamestown Family Health Clinic in Sequim, Washington, run by the Jamestown S'kallam Tribe. She realized that buprenorphine was not only successful in treating patients on illicit opioids, but buprenorphine could be used successfully to replace full agonist opioids in patients being treated for pain.  


    Her interest in working with patients on opioids continued when she became the medical director for the VA clinic in Port Angeles. When the VA started a program that allowed primary care physicians to use buprenorphine for veterans on opioids, she transferred to Tacoma. A native of the Northwest, she enjoys hiking and camping. She is a member of the Sunset Rotary Club where she has worked on "Masking the Homeless," promoting blood drives and other projects that support her community. She also enjoys Argentinian tango, which has been a COVID-challenged sport. 

    Dr. Kathleen M. Farrell, DO has no disclosures.

    Dr. Jeff Cashman DO, MS, FACOFP

    American College of Osteopathic Family Physicians

    Dr. Jeff Cashman DO, MS, FACOFP earned his Bachelor of Science degree in Industrial Engineering from Clemson University (2001), a master’s degree in Epidemiology from the Medical University of South Carolina (2006) and his Doctor of Osteopathic Medicine from the Philadelphia College of Osteopathic Medicine-Georgia Campus (2010). He completed his family medicine residency at AnMed Health Family medicine residency in Anderson, SC in 2013. 


    Dr. Cashman currently serves as the Associate Dean for Pre-Clinical Medical Education at the Edward Via College of Osteopathic Medicine – Carolinas Campus; previously serving as the Associate Dean of OMS-IV and Graduate Medical Education and Discipline Chair of Family Medicine. As well, he serves as a preceptor at the Spartanburg Regional Family Medicine Residency and is the team physician for Spartanburg High School. Prior to starting at VCOM-Carolinas, Dr. Cashman practiced inpatient and outpatient medicine at Mary Black Hospital in Spartanburg, SC. 


    Dr. Cashman serves as the Speaker of the House of Delegates for the South Carolina Medical Association and was the first Osteopathic President of the Spartanburg County Medical Society. He is involved with the South Carolina Osteopathic Medical Society and previously chaired the SCMA Bioethics Committee and SC Ethics Pandemic Task Force. He is the Leadership Director for VCOM-Carolinas’ HRSA funded Primary Care Champions Fellowship and was named to the SC Rural Physician Board.

    Jeff Cashman DO, MS, FACOFP has no disclosures.

    Dr. Rachael Sanchez, DO

    American College of Osteopathic Family Physicians

    Rachael Sanchez, DO, is a board-certified Doctor of Osteopathic Medicine with the American College of Osteopathic Family Physicians. In 2008, she earned her Doctor of Osteopathy from the Lake Erie College of Osteopathic Medicine in Bradenton, Florida and completed her transitional internship at the Naval Medical Center in Portsmouth, Virginia the following year. 

    Dr. Sanchez served as a general medical officer in the United States Navy and then completed her residency training in family practice at St. Petersburg General Hospital in St. Petersburg, Florida and her fellowship training was in addiction medicine at the University of Florida. She is a member of the American Osteopathic Association, American College of Family Practitioners, American Society of Addiction Medicine, Florida Osteopathic Medical Association and American College of Physicians. In 2023, Dr. Sanchez spoke on pain and substance use disorders (SUD) at the Florida Society of Addiction Medicine. 

    Dr. Racheal Sanchez, DO, has no disclosures.

    Dr Kristin Martin, DO MS, FAAFP

    American College of Osteopathic Family Physicians

    Dr Kristin Martin, DO MS, FAAFP is an emergency room and family practice physician based in ArkansasShe has worked as an Emergency Room medical director, Regional Medical Director, Hospitalist Director and is board certified by the American College of Osteopathic Family Medicine and a fellow of the American Academy of Family PhysiciansShe is adjunct faculty for University of Arkansas Medical Sciences, Arkansas College of Osteopathic Medicine and Debusk College of Osteopathic Medicine - Lincoln Memorial UniversityShe is the CEO of Arkansas Emergency Physician Associates, ER company and River Valley Medical Wellness outpatient clinic and currently is credentialed at ten different ER facilities in Arkansas ranging from high acuity medical centers to critical access hospitalsDr Martin earned her master's in biomedical science and Doctor of Osteopathy degree from Oklahoma State University - Center for Health Sciences in 2007She has previously served on the American College of Osteopathic Family Physicians, Board of Governors as a ResidentShe belongs to numerous organizations and has presented and published in areas from emergency medicine, family practice, opioid research, geriatrics and surgery. 

    Dr Kristin Martin, DO MS, FAAFP, has no disclosures.

    Dr. Melinda Ford, FACOFP

    American College of Osteopathic Family Physicians

    Dr. Melinda Ford, FACOFP dist. is an assistant professor at the Ohio University Heritage College of Osteopathic Medicine and also works for OhioHealth Physician Group Heritage College as a family medicine and addiction physician. Dr. Ford is board certified in family practice and osteopathic manipulative medicine with a certificate of qualification in addiction medicine. She has made numerous presentations and contributions in the area of addiction treatment, and currently serves as Chair of the board for the Ohio Professional's Health Program- Ohio's confidential monitoring program for impaired health professionals. 

    Dr. Melinda Ford, FACOFP has no disclosures.

    Dr. Anthony Dekker, Do, FACOFP, FAAFP, FAOAAM, DFASAM

    American College of Osteopathic Family Physicians

    Anthony Dekker, DO, FACOFP, FAAFP, FAOAAM, DFASAM is currently the Chief Medical Officer of the Division of Developmental Disabilities for the State of Arizona. He is committed to the mission of advocating for our members in DDD. Previously he retired after 37 years of federal service, lastly being a member of the Primary Care Service Line at the Gallup Indian Medical Center in the Indian Health Service. 


    Born and raised in Western Michigan, he graduated from Hope College in Holland Michigan. He completed his osteopathic education at Michigan State University in 1978. He completed his internship and family medicine residency at the Chicago College of Osteopathic Medicine and an Adolescent and Young Adult Medicine fellowship at Rush-Presbyterian-St Luke’s Medical Center in Chicago. As a Public Health Service Scholar, he served Chicago’s South Side for fourteen years. He was Professor and Chair of Family Medicine at the Kansas City University School of Medicine and Clinical Associate Professor at the University of Kansas Medical Center and the University of Missouri-Kansas City (Children’s Mercy Hospital) during his four years in Kansas City. He served in the Indian Health Service from 1998 to 2010 in the Phoenix Indian Medical Center as the Associate Director, Ambulatory Care and Community Health and 2020 to 2022 at the Gallup Indian Medical Center. He also served in the Department of Defense and the Northern Arizona VA Healthcare System. 


    Dr. Dekker is board certified in Family Practice and Osteopathic Manipulative Treatment, Adolescent and Young Adult Medicine, Addiction Medicine and Pain Medicine. He is a Fellow in numerous professional societies. His areas of expertise include developmental disorders, addiction medicine, chronic pain syndromes, informatics, high risk youth, domestic violence and behavioral health. Past faculty appointments include clinical professorships at George Washington University (Washington DC), and currently at the Burrell College of Osteopathic Medicine and Andrew Taylor Still University (Mesa, AZ).

    Dr. Anthony Dekker, Do, FACOFP, FAAFP, FAOAAM, DFASAM has no disclosures.

  • Contains 4 Component(s), Includes Credits

    CME Available: 1.5 AOA Category 1-A credits 1.5 AMA PRA Category 1 Credits™ The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management. • State the role of both prescription and illicit opioids within osteopathic care. Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy. • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD). • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment. • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management. • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.

    The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management.

    • State the role of both prescription and illicit opioids within osteopathic care.
    • Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy.
    • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD).
    • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment.
    • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management.
    • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.

    There are 4 lectures contained within this Live Case Forum series, which will be released from April 2024 through November 2024.

    • Live Case Forum - ACOFP (April 4, 2024): ACOFP 2024 Annual Convention and Scientific Seminars
    • Live Case Forum 1 (June 12, 2024): Live Virtual/Webcast
    • Live Case Forum 2 (August 13, 2024): Live Virtual/Webcast
    • In-person (September 20 - 22): OMED, San Antonio, TX
    • Live Case Forum - ACOI (November 1, 2024): ACOI 2024 Annual Convention and Scientific Sessions

    Disclosure Statements

    ACOFP and ACOI are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of an ineligible company. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACOFP and ACOI require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). Individuals in a position to control the content may include, but are not limited to, planning committee members, authors, faculty, speakers, reviewers, and activity staff. ACOFP and ACOI review all disclosed relationships to determine which are relevant and then work with the applicable contributors to mitigate the relevant financial relationships. No relevant financial relationships were identified for any individual in control of content for this specific activity series. 

    CME Credit and Designation Statements 

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Osteopathic Family Physicians (ACOFP) and American College of Osteopathic Internists (ACOI). ACOFP is accredited by the ACCME to provide continuing medical education for physicians. ACOFP designates this enduring activity series for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity. ACOFP is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. ACOFP designates this enduring activity series for a maximum of 1.5 AOA Category 1-A credits and will report continuing medical education (CME) credits commensurate with the physician’s participation in this program. 

    Support Acknowledgement 

    The activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. 

    Disclaimer

    ACOFP and ACOI present this information for educational purposes only. The content is provided solely by individuals who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. ACOFP, ACOI, and the supporter assume no liability for the information herein.

    DEA MATE Requirements

    As an accredited organization named in section 1263 of CAA 2023, ACOFP and ACOI have developed this series that may satisfy all or portions of your DEA training requirements.

    Annette T. Carron, DO, MACOI (she/her/hers)

    Director Geriatrics and Palliative Care

    Henry Ford Macomb Hospital

    Past-President ACOI
    Associate Professor, MSU-COM
    Medical Director Heart to Heart Hospice

    Dr. Jeff Cashman DO, MS, FACOFP

    American College of Osteopathic Family Physicians

    Dr. Jeff Cashman DO, MS, FACOFP earned his Bachelor of Science degree in Industrial Engineering from Clemson University (2001), a master’s degree in Epidemiology from the Medical University of South Carolina (2006) and his Doctor of Osteopathic Medicine from the Philadelphia College of Osteopathic Medicine-Georgia Campus (2010). He completed his family medicine residency at AnMed Health Family medicine residency in Anderson, SC in 2013. 


    Dr. Cashman currently serves as the Associate Dean for Pre-Clinical Medical Education at the Edward Via College of Osteopathic Medicine – Carolinas Campus; previously serving as the Associate Dean of OMS-IV and Graduate Medical Education and Discipline Chair of Family Medicine. As well, he serves as a preceptor at the Spartanburg Regional Family Medicine Residency and is the team physician for Spartanburg High School. Prior to starting at VCOM-Carolinas, Dr. Cashman practiced inpatient and outpatient medicine at Mary Black Hospital in Spartanburg, SC. 


    Dr. Cashman serves as the Speaker of the House of Delegates for the South Carolina Medical Association and was the first Osteopathic President of the Spartanburg County Medical Society. He is involved with the South Carolina Osteopathic Medical Society and previously chaired the SCMA Bioethics Committee and SC Ethics Pandemic Task Force. He is the Leadership Director for VCOM-Carolinas’ HRSA funded Primary Care Champions Fellowship and was named to the SC Rural Physician Board.

    Jeff Cashman DO, MS, FACOFP has no disclosures.

  • Contains 4 Component(s), Includes Credits

    CME Available: 1.5 AOA Category 1-A credits 1.5 AMA PRA Category 1 Credits™ The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management. • State the role of both prescription and illicit opioids within osteopathic care. Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy. • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD). • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment. • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management. • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.

    The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management.

    • State the role of both prescription and illicit opioids within osteopathic care.
    • Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy.
    • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD).
    • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment.
    • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management.
    • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.

    There are 4 lectures contained within this Live Case Forum series, which will be released from April 2024 through November 2024.

    • Live Case Forum - ACOFP (April 4, 2024): ACOFP 2024 Annual Convention and Scientific Seminars
    • Live Case Forum 1 (June 12, 2024): Live Virtual/Webcast
    • Live Case Forum 2 (August 13, 2024): Live Virtual/Webcast
    • In-person (September 20 - 22): OMED, San Antonio, TX
    • Live Case Forum - ACOI (November 1, 2024): ACOI 2024 Annual Convention and Scientific Sessions

    Disclosure Statements

    ACOFP and ACOI are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of an ineligible company. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACOFP and ACOI require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). Individuals in a position to control the content may include, but are not limited to, planning committee members, authors, faculty, speakers, reviewers, and activity staff. ACOFP and ACOI review all disclosed relationships to determine which are relevant and then work with the applicable contributors to mitigate the relevant financial relationships. No relevant financial relationships were identified for any individual in control of content for this specific activity series. 

    CME Credit and Designation Statements 

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Osteopathic Family Physicians (ACOFP) and American College of Osteopathic Internists (ACOI). ACOFP is accredited by the ACCME to provide continuing medical education for physicians. ACOFP designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity. ACOFP is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. ACOFP designates this enduring activity for a maximum of 1.5 AOA Category 1-A credits and will report continuing medical education (CME) credits commensurate with the physician’s participation in this program. 

    Support Acknowledgement 

    The activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. 

    Disclaimer

    ACOFP and ACOI present this information for educational purposes only. The content is provided solely by individuals who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. ACOFP, ACOI, and the supporter assume no liability for the information herein.

    DEA MATE Requirements

    As an accredited organization named in section 1263 of CAA 2023, ACOFP and ACOI have developed this series that may satisfy all or portions of your DEA training requirements.

    Robert Agnello, DO, FACOFP (he/him/his)

    Assistant Professor of Family Medicine

    Campbell University School of Osteopathic Medicine

    Dr. Robert N. Agnello is an assistant professor of family medicine and osteopathic manipulative medicine at Campbell University School of Osteopathic Medicine (CUSOM). He has been adjunct faculty since CUSOM’s inception in 2013, assisting the OMM department. Dr. Agnello is board-certified in family medicine since 2001 and holds a CAQ in pain medicine since 2017. His clinical interests lie in pain management through integrative osteopathic medicine, combining various strategies. His research focuses on complementary care modalities and their impact on pain, including osteopathic manipulation, auricular acupuncture, and functional medicine. Dr. Agnello is actively involved in professional organizations such as the American College of Osteopathic Family Physicians (ACOFP), American Osteopathic Association (AOA), and American Academy of Osteopathy (AAO).

    Dr. Robert N. Agnello, DO, FACOFP has no disclosures.

    Dr. Kathleen M. Farrell, DO

    American College of Osteopathic Family Physicians

    Kathleen M. Farrell, DO, is a graduate of the Arizona College of Osteopathic Medicine. She is certified in family medicine with the American Osteopathic Board of Family Physicians and in addiction medicine with American Osteopathic Academy of Addiction Medicine. Before obtaining her osteopathic medical degree, she earned her bachelor's degree in social welfare at the University of Washington. She is currently working for the VA in the opioid safety clinic in the pain department at American Lakes in Tacoma, Washington.  


    She got her "XF" soon after she got out of residency and when she started a practice with a Valley Family Health Care, a federally qualified health center in New Plymouth, Idaho. While in Idaho, she founded the Idaho Osteopathic Physicians Association and started using buprenorphine to treat her patients on illicit opioidsShe continued this work when she moved to Port Angeles, Washington, to work at the Jamestown Family Health Clinic in Sequim, Washington, run by the Jamestown S'kallam Tribe. She realized that buprenorphine was not only successful in treating patients on illicit opioids, but buprenorphine could be used successfully to replace full agonist opioids in patients being treated for pain.  


    Her interest in working with patients on opioids continued when she became the medical director for the VA clinic in Port Angeles. When the VA started a program that allowed primary care physicians to use buprenorphine for veterans on opioids, she transferred to Tacoma. A native of the Northwest, she enjoys hiking and camping. She is a member of the Sunset Rotary Club where she has worked on "Masking the Homeless," promoting blood drives and other projects that support her community. She also enjoys Argentinian tango, which has been a COVID-challenged sport. 

    Dr. Kathleen M. Farrell, DO has no disclosures.

  • Contains 4 Component(s), Includes Credits

    CME Available: 1.5 AOA Category 1-A credits 1.5 AMA PRA Category 1 Credits™ The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management. • State the role of both prescription and illicit opioids within osteopathic care. Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy. • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD). • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment. • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management. • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.

    The goal of this series is to provide osteopathic primary care clinicians, with evidence-based, multidisciplinary strategies to improve knowledge and competence of pain management with non-pharmacologic and non-opioid therapies and the methodology to safely integrate opioids into treatment regimens to mitigate risks of opioid use disorder while addressing current barriers to optimal management.

    • State the role of both prescription and illicit opioids within osteopathic care.
    • Discover the appropriate circumstances for prescribing full agonist opioids for chronic pain, guided by osteopathic philosophy.
    • Analyze case studies to identify opportunities for using Buprenorphine and Methadone in the treatment of chronic pain or Opioid Use Disorder (OUD).
    • Evaluate the skills in early detection of OUD by learning tools and techniques for assessment.
    • Assess the risk/benefit profiles of starting, stopping, or modifying opioid prescriptions for pain management.
    • Develop tailored treatment plans for patients with pain or OUD to include the significance of continuous management and support and incorporate a range of treatment options such as medication-assisted treatment, behavioral therapies, and support services.

    There are 4 lectures contained within this Live Case Forum series, which will be released from April 2024 through November 2024.

    • Live Case Forum - ACOFP (April 4, 2024): ACOFP 2024 Annual Convention and Scientific Seminars
    • Live Case Forum 1 (June 12, 2024): Live Virtual/Webcast
    • Live Case Forum 2 (August 13, 2024): Live Virtual/Webcast
    • In-person (September 20 - 22): OMED, San Antonio, TX
    • Live Case Forum - ACOI (November 1, 2024): ACOI 2024 Annual Convention and Scientific Sessions

    Disclosure Statements

    ACOFP and ACOI are committed to providing learners with high-quality CME/CE activities that promote improvements in health care and not those of an ineligible company. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACOFP and ACOI require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). Individuals in a position to control the content may include, but are not limited to, planning committee members, authors, faculty, speakers, reviewers, and activity staff. ACOFP and ACOI review all disclosed relationships to determine which are relevant and then work with the applicable contributors to mitigate the relevant financial relationships. No relevant financial relationships were identified for any individual in control of content for this specific activity series. 

    CME Credit and Designation Statements 

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Osteopathic Family Physicians (ACOFP) and American College of Osteopathic Internists (ACOI). ACOFP is accredited by the ACCME to provide continuing medical education for physicians. ACOFP designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity. ACOFP is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. ACOFP designates this enduring activity for a maximum of 1.5 AOA Category 1-A credits and will report continuing medical education (CME) credits commensurate with the physician’s participation in this program. 

    Support Acknowledgement 

    The activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. 

    Disclaimer

    ACOFP and ACOI present this information for educational purposes only. The content is provided solely by individuals who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. ACOFP, ACOI, and the supporter assume no liability for the information herein.

    DEA MATE Requirements

    As an accredited organization named in section 1263 of CAA 2023, ACOFP and ACOI have developed this series that may satisfy all or portions of your DEA training requirements.

    Robert Agnello, DO, FACOFP (he/him/his)

    Assistant Professor of Family Medicine

    Campbell University School of Osteopathic Medicine

    Dr. Robert N. Agnello is an assistant professor of family medicine and osteopathic manipulative medicine at Campbell University School of Osteopathic Medicine (CUSOM). He has been adjunct faculty since CUSOM’s inception in 2013, assisting the OMM department. Dr. Agnello is board-certified in family medicine since 2001 and holds a CAQ in pain medicine since 2017. His clinical interests lie in pain management through integrative osteopathic medicine, combining various strategies. His research focuses on complementary care modalities and their impact on pain, including osteopathic manipulation, auricular acupuncture, and functional medicine. Dr. Agnello is actively involved in professional organizations such as the American College of Osteopathic Family Physicians (ACOFP), American Osteopathic Association (AOA), and American Academy of Osteopathy (AAO).

    Dr. Robert N. Agnello, DO, FACOFP has no disclosures.

    Dr. Rachael Sanchez, DO

    American College of Osteopathic Family Physicians

    Rachael Sanchez, DO, is a board-certified Doctor of Osteopathic Medicine with the American College of Osteopathic Family Physicians. In 2008, she earned her Doctor of Osteopathy from the Lake Erie College of Osteopathic Medicine in Bradenton, Florida and completed her transitional internship at the Naval Medical Center in Portsmouth, Virginia the following year. 

    Dr. Sanchez served as a general medical officer in the United States Navy and then completed her residency training in family practice at St. Petersburg General Hospital in St. Petersburg, Florida and her fellowship training was in addiction medicine at the University of Florida. She is a member of the American Osteopathic Association, American College of Family Practitioners, American Society of Addiction Medicine, Florida Osteopathic Medical Association and American College of Physicians. In 2023, Dr. Sanchez spoke on pain and substance use disorders (SUD) at the Florida Society of Addiction Medicine. 

    Dr. Racheal Sanchez, DO, has no disclosures.

  • Contains 35 Product(s)

    2024 Clinical Challenges in Hospital Medicine (On-Demand) CME Credit Available: This activity offers a total of 26 hours of AOA Category 1A credits and AMA PRA Category 1 Credits™. Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: • Learn new treatments for diabetes and CKM syndrome. • Get updates on obesity management. • Summarize the latest guideline strategies for blood and blood product transfusions. • Discuss renal failure in the intensive care setting. • Review the latest updates in GI therapies. • Identify new approaches to acutely ill patients on chronic immunosuppressive medicine. • Review updates to hospital isolation guidelines. • Review updates on care of the transgender patient. • Learn new billing code updates. • Review best practices in the management of hospital delirium and agitation. • Learn updates on meeting hospital goal metrics.

    2024 Clinical Challenges in Hospital Medicine (On-Demand)

    The ACOI 2024 Clinical Challenges in Hospital Medicine offers the latest updates and tips for hospital-based internists and subspecialists to manage care in the inpatient setting.

    CME Credit Available:

    This activity offers a total of 26 hours of AOA Category 1A credits and AMA PRA Category 1 Credits™.

    Note: ACOI reports credits to the AOA after the end of each quarter. 

    Learning Objectives:

    • Learn new treatments for diabetes and CKM syndrome.
    • Get updates on obesity management.
    • Summarize the latest guideline strategies for blood and blood product transfusions.
    • Discuss renal failure in the intensive care setting.
    • Review the latest updates in GI therapies.
    • Identify new approaches to acutely ill patients on chronic immunosuppressive medicine.
    • Review updates to hospital isolation guidelines.
    • Review updates on care of the transgender patient.
    • Learn new billing code updates.
    • Review best practices in the management of hospital delirium and agitation.
    • Learn updates on meeting hospital goal metrics.

    Release & Review Date: 

    This activity is valid from July 31, 2024, until July 31, 2027.

  • Contains 70 Product(s)

    CME Credit Available: This activity offers a total of 37.25 hours of AOA Category 1A credits and AMA PRA Category 1 Credits™. Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: • Revise and refresh knowledge of core topics in internal medicine and the subspecialties through discussion of common and uncommon clinical problems. • Apply successful strategies to respond to challenging scenarios. • Synthesize and implement changes in clinical practice in accordance with recent advances, guidelines, and evidence-based practice.

    2024 Internal Medicine Comprehensive Update (On-Demand)

    The ACOI 2024 Internal Medicine Comprehensive Update will help you to maintain best-practice knowledge and skills in all areas of practice of internal medicine and subspecialty topics.

    CME Credit Available:

    This activity offers a total of 37.25 hours of AOA Category 1A credits and AMA PRA Category 1 Credits™.

    Note: ACOI reports credits to the AOA after the end of each quarter. 

    Learning Objectives:

    • Revise and refresh knowledge of core topics in internal medicine and the subspecialties through discussion of common and uncommon clinical problems.
    • Apply successful strategies to respond to challenging scenarios.
    • Synthesize and implement changes in clinical practice in accordance with recent advances, guidelines, and evidence-based practice.

    Release & Review Date: 

      This activity is valid from July 31, 2024, until July 31, 2027.

  • Contains 6 Component(s), Includes Credits

    CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: Those participating in this activity will receive information that should allow them to: • The differences for split shared visits in 2024. • Physician rules for supervision in 2024. • The new Hospital and Observation Services codes and guidelines.

    CME Credit Available: 

    This activity offers .75 1A AOA

    Note: ACOI reports credits to the AOA after the end of each quarter.  

    Learning Objectives:

    Those participating in this activity will receive information that should allow them to: 

    • The differences for split shared visits in 2024.
    • Physician rules for supervision in 2024.
    • The new Hospital and Observation Services codes and guidelines.

    Conflict of Interest Disclosures:

    ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

    Jill M. Young, CPC, CEDC, CIMC, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

    Release & Review Date:

    This activity is valid from July 31, 2024, until July 31, 2027.

    Jill M. Young, CPC, CEDC, CIMC

    Principal Consultant

    Young Medical Consulting, LLC

    Jill Young, CEMC, CPC, CEDC, CIMC, is the founder of Young Medical Consulting a company formed 20 years ago to meet the educational needs of both physicians and their staff. She has over 40 years of medical experience with a diverse background in all areas of the office from billing and coding to clinical, auditing and management. She has been published in a wide range of periodicals and presented over one hundred lectures both in person and via audioconferences and webinars.

  • Contains 6 Component(s), Includes Credits

    CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: Those participating in this activity will receive information that should allow them to: • Scripting options to counsel patients/families facing serious illness. • What assistance is available to have difficult conversations. • Preemptive and management strategies for each conversation.

    CME Credit Available: 

    This activity offers .75 1A AOA

    Note: ACOI reports credits to the AOA after the end of each quarter.  

    Learning Objectives:

    Those participating in this activity will receive information that should allow them to: 

    • Scripting options to counsel patients/families facing serious illness.
    • What assistance is available to have difficult conversations.
    • Preemptive and management strategies for each conversation.

    Conflict of Interest Disclosures:

    ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

    Annette T. Carron, DO, MACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

    Release & Review Date:

    This activity is valid from July 31, 2024, until July 31, 2027.

    Annette T. Carron, DO, MACOI (she/her/hers)

    Director Geriatrics and Palliative Care

    Henry Ford Macomb Hospital

    Past-President ACOI
    Associate Professor, MSU-COM
    Medical Director Heart to Heart Hospice

  • Contains 6 Component(s), Includes Credits

    CME Credit Available: This activity offers .75 1A AOA Note: ACOI reports credits to the AOA after the end of each quarter. Learning Objectives: Those participating in this activity will receive information that should allow them to: • The key challenges and factors influencing the transition from inpatient to outpatient management in chronic pain patients. • Best practices for developing personalized care plans to facilitate seamless transitions and improve patient outcomes. • Challenges associated with transitions and solutions to overcome barriers for more effective chronic pain management.

    CME Credit Available: 

    This activity offers .75 1A AOA

    Note: ACOI reports credits to the AOA after the end of each quarter.  

    Learning Objectives:

    Those participating in this activity will receive information that should allow them to: 

    • The key challenges and factors influencing the transition from inpatient to outpatient management in chronic pain patients.
    • Best practices for developing personalized care plans to facilitate seamless transitions and improve patient outcomes.
    • Challenges associated with transitions and solutions to overcome barriers for more effective chronic pain management.

    Conflict of Interest Disclosures:

    ACOI requires each planner and presenter to identify all conflicts of interest and mitigate risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

    Jean Storm, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose.  

    Release & Review Date:

    This activity is valid from July 31, 2024, until July 31, 2027.

    Jean Storm, DO

    Medical Director, Quality Insights

    Clinical Support Physician, Optum/United Healthcare